Posted inBiotechnology
Major Music Events Linked to Subclinical Hearing Damage
In a groundbreaking study published in Scientific Reports, researchers have unveiled startling evidence concerning the auditory implications of large-scale music…
Posted inMedical Technology
Abbott launches AI-based Libre Assist, its new in-app feature for meal planning
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s…
Posted inBiotechnology
Incretin Modulation Revolutionizes Diabetes, Heart, and Kidney Health
Recent advancements in diabetes therapy have taken a significant turn as researchers delve into incretin modulation, revealing its profound potential…
Posted inBiotechnology
Unveiling Maclura Tricuspidata’s Complete Mitochondrial Genome
In a groundbreaking study, researchers have unveiled the complete mitochondrial genome of Maclura tricuspidata, a plant species common to East…
Posted inBiotechnology
AI Predicts Ice Hockey Impact with Strain Analysis
In recent years, the intersection of sports and technology has opened doors to innovative methodologies that enhance performance and safety.…
Posted inBiotechnology
Zenas’ stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit
A phase 3 study of Zenas BioPharma's autoimmune disease candidate has hit its primary endpoint. But, with the result falling short…
Posted inBiotechnology
Aktis Oncology aims for $209M windfall from 1st biotech IPO of 2026
Aktis Oncology is aiming to bring in $182 million—or more—from what looks set to be the first biotech IPO of…
Posted inBiotechnology
Efficient Tail Risk Assessment for Power Systems
In an era where the reliability and stability of power systems underpin the very fabric of modern society, the capacity…
Posted inBiotechnology
Novel Clostridium Phages Combat Chicken Meat Contamination
In an era where food safety increasingly comes into focus, researchers have turned their attention to an innovative approach for…
Posted inBiotechnology
Sanofi’s latest autoimmune bispecific pact with AI biotech could reach $2.5B
Sanofi has returned to U.S. artificial intelligence research biotech Earendil Labs for another significant autoimmune and immunology development pact. The…